These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1823946)

  • 1. Abnormalities of lipoprotein composition in renal insufficiency.
    Attman PO; Alaupovic P
    Prog Lipid Res; 1991; 30(2-3):275-9. PubMed ID: 1823946
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid abnormalities in progressive renal insufficiency.
    Attman PO; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1997; 120():1-10. PubMed ID: 9257042
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid and lipoprotein abnormalities in renal disease.
    Segura R; Gotto AM
    Perspect Nephrol Hypertens; 1976; 3():159-200. PubMed ID: 814531
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of plasma lipids on kidney function in primary renal diseases].
    Yosefy C; Schnieder R
    Harefuah; 1999 Nov; 137(9):414-7. PubMed ID: 11419048
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI).
    Kimak E; Solski J; Janicka L; Zagojska M
    Int Urol Nephrol; 1999; 31(2):263-7. PubMed ID: 10481973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
    Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative abnormalities of lipoprotein particles in chronic hemodialysis patients.
    Parra HJ; Cachera C; Equagoo K; Dracon M; Fruchart JC; Tacquet A
    Adv Exp Med Biol; 1988; 243():283-7. PubMed ID: 3223421
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of fat load on serum lipids in patients with renal disease.
    Kokot F; Kuska J; Pakula E; Koziak H; Pietrek J; Kowalik M
    Nephron; 1971; 8(6):549-58. PubMed ID: 5136622
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids in renal insufficiency.
    Heuck CC; Ritz E; Liersch M; Mehls O
    Am J Clin Nutr; 1978 Sep; 31(9):1547-53. PubMed ID: 210650
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolism in pregnancy. VI. Lipoprotein composition and hepatic lipids in the fed pregnant rat.
    Montes A; Humphrey J; Knopp RH; Childs MT
    Endocrinology; 1978 Oct; 103(4):1031-8. PubMed ID: 217663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid metabolism in chronic hemodialysis therapy].
    Okada N; Tsuchimoto I; Makihata T; Tominaga H; Iwahata I
    Rinsho Byori; 1971 Aug; 19():Suppl:301. PubMed ID: 5167991
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of time elapsed since transplantation on lipid and lipoprotein abnormalities in renal transplant patients: role of maintenance prednisone and gender influence.
    Lloveras J; Sentí M; Puig JM; Barbosa F; Oliveras A; Aubó C; Navarro G; Masramon J
    Transplant Proc; 1997; 29(1-2):212-5. PubMed ID: 9122967
    [No Abstract]   [Full Text] [Related]  

  • 18. Apolipoproteins and lipoproteins of human plasma: significance in health and in disease.
    Kostner GM
    Adv Lipid Res; 1983; 20():1-43. PubMed ID: 6230900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry.
    Kuklenyik Z; Jones JI; Gardner MS; Schieltz DM; Parks BA; Toth CA; Rees JC; Andrews ML; Carter K; Lehtikoski AK; McWilliams LG; Williamson YM; Bierbaum KP; Pirkle JL; Barr JR
    PLoS One; 2018; 13(4):e0194797. PubMed ID: 29634782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
    Oyelola OO; Ajayi AA; Babalola RO; Stein EA
    J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.